Specialty Respiratory Pipeline
Glenmark’s specialty business is focused on identifying products and formulations that fulfill unique and unmet needs for physician specialists who treat a range of conditions, with our initial efforts focused on respiratory and dermatology. Specialty assets are being commercialized by Glenmark Therapeutics Inc., USA, a wholly-owned subsidiary of Glenmark Holding, SA.
RYALTRISTM* NASAL SPRAY (olopatadine hydrochloride and mometasone furoate monohydrate nasal spray, also known as GSP 301)
Seasonal Allergic Rhinitis
Steroid + antihistamine